<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T04:00:54Z</responseDate>
  <request identifier="oai:figshare.com:article/33871852" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33871852</identifier>
        <datestamp>2026-09-17T05:30:50Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Mapping the physical topology of the tumor immune microenvironment: macroscopic image fractals as surrogate markers for immune exclusion phenotype and treatment resistance in colorectal cancer liver metastases.docx</dc:title>
          <dc:creator>Guo Ziyi (21686216)</dc:creator>
          <dc:creator>Wentao Zhou (5867126)</dc:creator>
          <dc:creator>Kailin Zou (24364343)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>colorectal cancer liver metastases</dc:subject>
          <dc:subject>explainable artificial intelligence</dc:subject>
          <dc:subject>fractal dimension</dc:subject>
          <dc:subject>immune exclusion phenotype</dc:subject>
          <dc:subject>treatment resistance</dc:subject>
          <dc:subject>tumor immune microenvironment</dc:subject>
          <dc:description>Background&lt;p&gt;The spatial tumor immune microenvironment (TIME) determines therapy response in colorectal cancer liver metastases (CRLM). To overcome biopsy sampling bias, this study investigates multimodal macroscopic image fractal dynamics to non-invasively map immune physical barriers and metabolic states, constructing a multi-scale immune-radiomics joint score (IRJS) for robust prognostic stratification and exploratory assessment of treatment resistance.&lt;/p&gt;Materials and methods&lt;p&gt;This dual-center observational study enrolled 270 CRLM patients with dual-modality imaging (contrast-enhanced magnetic resonance imaging, CE-MRI, 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed-tomography, &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT) and digital spatial pathology. Patients were spatiotemporally divided into training (n=150), prospective temporal validation (n=45), and external validation (n=75) cohorts. Structural (FD_MRI) and metabolic (FD_PET) fractal dimensions were combined with the systemic immune-inflammation index (SII) and KRAS status to build the IRJS using XGBoost, utilizing the SHAP framework to evaluate mapping mechanisms.&lt;/p&gt;Results&lt;p&gt;FD_MRI positively correlated with α-SMA&lt;sup&gt;+&lt;/sup&gt; pro-fibrotic stromal density (r = 0.684), which may reflect the mechanical barrier excluding CD8&lt;sup&gt;+&lt;/sup&gt; T cells. FD_PET showed a significant association with core hypoxia (HIF-1α) and systemic immune exhaustion. IRJS robustly identified the immune-inflamed phenotype across training, temporal, and external validation cohorts (AUCs: 0.921, 0.886, 0.862, respectively). The IRJS-identified inflamed phenotype was an independent protective factor for overall survival (HR = 0.31, P &lt; 0.001). Furthermore, IRJS demonstrated significant clinical net reclassification improvement (NRI = 0.384, P &lt; 0.001) and net clinical benefit in decision curve analysis.&lt;/p&gt;Conclusion&lt;p&gt;Dual-modal fractal dynamics provide non-invasive surrogate markers for mechanical constraints and metabolic exhaustion in CRLM. The IRJS model enables robust spatiotemporal assessment of immune evasion, offering multidisciplinary teams a potential framework to explore non-invasive biopsy decisions, prognostic stratification, and provide exploratory insights into potential immunotherapy resistance.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-17T05:30:50Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1889571.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Mapping_the_physical_topology_of_the_tumor_immune_microenvironment_macroscopic_image_fractals_as_surrogate_markers_for_immune_exclusion_phenotype_and_treatment_resistance_in_colorectal_cancer_liver_metastases_docx/33871852</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
